Itaconix (ITX) AI Stock Analysis

• Market Cap: £14.30M
• Dividend Yield: N/A
• Average Volume (3M): 8.23K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.09
• Revenue Growth: 25.56%
• EPS Growth: 35.12%
• Country: UK
• Employees: 22
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): -0.03
• Shares Outstanding: 13,486,122
• 10 Day Avg. Volume: 5,692
• 30 Day Avg. Volume: 8,228
• PEG Ratio: -0.24
• Price to Book (P/B): 2.38
• Price to Sales (P/S): 3.42
• P/FCF Ratio: -6.66
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £325.00
• Price Target Upside: 176.60% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 53 Neutral
• Price Target: 118.00p ▲(0.43% Upside)

Itaconix's overall stock score is driven by its financial performance and optimistic earnings call outlook, despite technical and valuation challenges. The company shows potential for future growth, but current profitability and cash flow issues weigh on the score.

Positive Factors

Revenue Growth

Significant revenue growth indicates strong market demand and successful product adoption, positioning Itaconix for future expansion.

Low Financial Leverage

Low financial leverage reduces risk and provides financial stability, allowing Itaconix to invest in growth opportunities without excessive debt burden.

Strong North American Sales

Strong sales in North America highlight Itaconix's competitive position and potential for continued growth in a key market.

Negative Factors

Profitability Challenges

Ongoing profitability challenges with negative margins indicate operational inefficiencies, which could hinder long-term financial health.

Customer Concentration Risk

High customer concentration poses a risk to revenue stability, as losing key customers could significantly impact financial performance.

Negative Cash Flow

Negative cash flow indicates liquidity issues, which can constrain Itaconix's ability to fund operations and invest in growth initiatives.

Itaconix Business Overview & Revenue Model

Company Description

Itaconix (ITX) is a sustainable materials company that specializes in the development and production of innovative biopolymers derived from renewable resources. Operating primarily in the specialty chemicals sector, Itaconix focuses on delivering eco-friendly alternatives for various applications, including personal care, household products, and industrial uses. The company's core products include biodegradable polymers that serve as thickeners, binders, and film-forming agents, offering a sustainable solution to traditional petrochemical-based materials.

How the Company Makes Money

Itaconix generates revenue through the sale of its biopolymer products to manufacturers in various industries, including personal care, cleaning, and agriculture. The company utilizes a business-to-business (B2B) sales model, where it partners with manufacturers looking to incorporate sustainable ingredients into their formulations. Key revenue streams include direct sales of their proprietary products and licensing agreements with partners who wish to utilize Itaconix's technology in their own production processes. Additionally, Itaconix may benefit from strategic partnerships with larger companies seeking to enhance their sustainability efforts, which can lead to increased sales volume and market penetration.

Itaconix Financial Statement Overview

Summary

Itaconix shows revenue growth and a strong equity base, but faces challenges with profitability and cash flow sustainability. Despite low leverage, achieving positive net income and free cash flow is crucial for long-term stability.

Income Statement

The company shows a modest revenue growth from $6.22M in 2023 to $6.50M in 2024, indicating a positive trend. However, the net income remains negative, with a net profit margin of -28.68% in 2024, suggesting ongoing profitability challenges. The EBIT and EBITDA margins are also negative, highlighting operational inefficiencies.

Balance Sheet

The balance sheet reflects strong equity with a debt-to-equity ratio of 0.21, implying low financial leverage and reduced risk. The equity ratio is 70.80%, indicating a stable capital structure. However, the company has negative net income, which impacts return on equity calculations.

Cash Flow

The free cash flow is negative, showing a decline, which is a concern for liquidity. However, the operating cash flow to net income ratio is unavailable due to negative values, complicating cash flow assessment. The company has managed to secure substantial financing cash flows in 2023, improving liquidity temporarily.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	9.28M	6.50M	6.17M	4.57M	2.60M	2.42M
Gross Profit	3.04M	2.26M	1.93M	1.49M	518.89K	847.62K
EBITDA	-1.31M	-1.52M	-1.06M	-1.78M	-58.17K	-885.54K
Net Income	-1.59M	-1.86M	-1.54M	-2.01M	-330.83K	-1.28M
Balance Sheet
Total Assets	10.12M	13.18M	11.98M	2.06M	2.43M	3.32M
Cash, Cash Equivalents and Short-Term Investments	4.12M	6.73M	6.86M	493.85K	506.29K	1.06M
Total Debt	1.36M	1.97M	2.45M	428.08K	366.19K	745.37K
Total Liabilities	3.22M	3.85M	3.10M	2.69M	1.95M	3.78M
Stockholders Equity	6.91M	9.33M	8.88M	-631.78K	481.09K	-459.07K
Cash Flow
Free Cash Flow	-1.95M	-3.34M	-2.18M	-226.62K	-1.55M	-849.83K
Operating Cash Flow	-1.61M	-2.75M	-1.38M	―	-1.50M	-849.83K
Investing Cash Flow	2.70M	5.95M	-6.20M	―	-34.90K	15.60K
Financing Cash Flow	-441.15K	-279.00K	9.16M	156.52K	968.11K	1.34M

Itaconix Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 117.50
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ITX, the sentiment is Positive. The current price of 117.5 is above the 20-day moving average (MA) of 117.42, above the 50-day MA of 110.96, and above the 200-day MA of 116.08, indicating a bullish trend. The MACD of 1.98 indicates Positive momentum. The RSI at 59.92 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:ITX.

Itaconix Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
IOF	60 Neutral	£43.17M	11.60	10.25%	―	8.48%	29.33%
HAYD	55 Neutral	£28.10M	-1.76	―	―	-27.64%	35.09%
ITX	53 Neutral	£14.30M	-14.83	-12.88%	―	25.56%	35.12%
HDD	53 Neutral	£8.08M	-18.64	-11.10%	―	14.51%	77.27%
DCTA	45 Neutral	£8.09M	-2.23	-78.76%	―	-24.85%	40.28%
GEX	31 Underperform	£6.24M	-0.80	―	―	―	―

Itaconix Corporate Events

Itaconix plc’s Earnings Call: Growth Amid Challenges

The recent earnings call from Itaconix plc painted a picture of optimism and growth, despite some underlying challenges. The company reported significant revenue growth and improved financial performance, suggesting a promising path towards profitability. However, the call also highlighted some hurdles, such as low profit margins in certain segments and risks associated with customer concentration. Overall, the sentiment was optimistic, with plans for future expansion on the horizon.

Itaconix Achieves Record Half-Year Revenues and Expands Product Offerings

Itaconix plc reported record half-year revenues of $4.8 million for the period ending June 30, 2025, marking a significant milestone in establishing its products as core ingredients in sustainable consumer products. The company has launched BIO*Asterix® and expanded its SPARX™ collaborations, resulting in three distinct revenue streams. Itaconix has also extended its partnership with Croda and mitigated international trade risks, while investing in marketing and supply chain resilience. With a strong balance sheet and a growing pipeline of opportunities, Itaconix is well-positioned for sustained growth and long-term shareholder value.

The most recent analyst rating on (GB:ITX) stock is a Buy with a £325.00 price target. To see the full list of analyst forecasts on Itaconix stock, see the GB:ITX Stock Forecast page.

Itaconix to Release Interim Results and Host Live Presentation

Itaconix has announced that it will release its Interim Results for the year ended 30 June 2025 on 15 September 2025. The company will also hold a live presentation on the same day, open to all interested parties, allowing stakeholders to engage and submit questions, highlighting its commitment to transparency and stakeholder engagement.

The most recent analyst rating on (GB:ITX) stock is a Buy with a £325.00 price target. To see the full list of analyst forecasts on Itaconix stock, see the GB:ITX Stock Forecast page.